Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer.

Ida ParisStefano CianciGiuseppe VizzielliAnna FagottiGabriella FerrandinaSalvatore Gueli AllettiBarbara CostantiniFrancesco CosentinoEttore CapoluongoMariangela PasqualoniGiovanni Scambia

Published in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group (2018)

Our data suggest that HIPEC can be safely introduced in the upfront therapy of advanced ovarian cancer.

Keyphrases

electronic health record
big data
machine learning
bone marrow
data analysis
deep learning
cell therapy